IoMT Security in 2026: How to Connect Medical Devices Without Creating a HIPAA Liability

99% of hospitals are currently managing at least one IoMT device with a known exploited vulnerability.

This is a number worth reading twice.

Not an obscure vulnerability. A known, actively exploited one in 99% of hospitals.

If you are a CTO, CIO, or Head of R&D at a health IT company or a digital health platform, that number describes your customers. And in many cases, it describes infrastructure your product is directly connected to.

By 2026, smart hospitals are deploying over 7 million IoMT devices, more than double the number in 2021. Every one of those devices is a potential entry point into a hospital network. And every one of them that touches Protected Health Information (PHI) creates HIPAA obligations.

This guide covers what CTOs and health IT leaders need to know in 2026 to connect medical devices without creating a compliance liability.

Though first let's understand why such IoMT Security is an important factor in today's era.

Why IoMT Is Now the Highest-Risk Surface in Healthcare

IoMT security is different from standard enterprise IT security in three specific ways that make it harder to manage and easier to exploit.

1. Devices were not built for security

Most medical devices were designed for clinical function, not network connectivity. Many run on operating systems that are years or decades old.

60% of IoMT devices are end-of-life with no available security patches. You cannot patch what the manufacturer no longer supports, and you cannot replace devices that are FDA-cleared and still clinically in use.

2. Vulnerabilities accumulate faster than they are fixed

Medical devices average 6.2 vulnerabilities per device, far exceeding typical enterprise hardware.

A study deploying honeypot servers that simulated medical environments recorded 1.6 million simulated attacks over 12 months, roughly one every 20 seconds.

3. The breach cost is the highest in any industry

The average healthcare breach cost reached $10.22 million in the US in 2025, up 9.2% from the previous year.

When that breach originates from a connected medical device, the liability extends across HIPAA, potentially FDA, and in international markets, MDR and local data protection laws.

These are no longer best practices. They are the law that needs to be followed. And they apply to every device that touches PHI, including your connected medical hardware.

Read More: HIPAA in 2026: What Changed & What Your Engineering Team Must Know

4 Major Layers of IoMT Security Your Architecture Needs

Layer 1: Device Identity and Authentication

The first control question for any IoMT deployment is simple: how does your network know this specific device is the device it claims to be?

Default device credentials are one of the most exploited attack vectors in healthcare. Weak default settings and passwords make devices easy targets for attackers.

What your IoMT architecture needs:

• Unique device identity: Every device must have a cryptographically unique identifier, not a shared credential or a factory-default username and password. This typically means deploying a device certificate via a Public Key Infrastructure (PKI) system.
• Certificate-based authentication: Before a device is allowed to communicate on your clinical network, it must present a valid certificate issued by your PKI. This prevents unauthorized devices from joining the network even if they have physical access to a network port.
• Zero-trust device access: Treat every device as untrusted until it has authenticated. Do not assume that a device physically located in a clinical space is automatically safe to grant network access.
• Regular credential rotation: For devices that use password-based authentication (many legacy devices cannot support certificate-based auth), enforce regular credential rotation and never allow factory defaults in production.

What to do with legacy devices that cannot support modern authentication:

• Document them explicitly in your HIPAA risk assessment as compensating controls are required
• Apply network segmentation (Layer 2 below) to isolate them
• Require physical access controls as a compensating measure
• Track their end-of-life dates and plan replacement cycles

Layer 2: Network Segmentation

This is the single most impactful control for limiting the damage of an IoMT breach. Network segmentation means separating your medical device network from your clinical IT network, your administrative network, and your internet-facing systems.

When Change Healthcare was breached in 2024, impacting 192 million patient records, flat networks were a significant factor in how far the breach spread. A device compromised on a flat network can communicate with everything else on that network.

A properly segmented network means a compromised infusion pump cannot talk to your EHR, your billing system, or your staff laptops.

Segmentation architecture for IoMT environments:

Practical implementation notes you should know:

• Use VLANs as the baseline segmentation mechanism
• Apply firewall rules between each zone with explicit allow lists, not default-allow policies
• Monitor all cross-zone traffic with a network detection and response (NDR) tool
• Apply data minimization and maintain immutable, offline backups for critical systems and test restore times against clinical recovery time objectives.

Layer 3: Data Encryption and Transmission Security

Over 1 million IoT medical devices leaked sensitive patient data in 2025 due to missing encryption. This is a HIPAA violation at scale, and it is one of the most commonly cited gaps in OCR enforcement actions.

Encryption requirements for IoMT in 2026:

• Data in transit: All PHI transmitted from a medical device to any receiving system must be encrypted. TLS 1.2 minimum, TLS 1.3 preferred. Legacy devices that cannot support TLS require a local gateway that handles encryption before data leaves the device network.
• Data at rest: PHI stored on any device, gateway, or server must be encrypted at rest. For devices with local storage (imaging systems, monitoring equipment), verify the manufacturer's encryption implementation and document it.
• End-to-end validation: Encryption in transit means the entire path from device to final data store, not just the last mile. Map every hop in your data flow and confirm encryption at each point.
• Key management: Encryption without proper key management is not meaningful security. Use a dedicated key management service (AWS KMS, Azure Key Vault, or an equivalent) rather than storing keys in application configuration files.

Layer 4: Continuous Monitoring and Vulnerability Management

52% of IoMT devices run on Windows, yet only 10% of these devices have active anti-malware protection. A static security posture is not viable when your device estate is this exposed.

What continuous IoMT monitoring requires:

• Asset inventory: You cannot secure what you cannot see. Maintain a live, complete inventory of every connected device: model, firmware version, operating system, network location, and clinical function. Tools like Claroty, Medigate (now part of Claroty), or Ordr automate this for large device estates.
• Vulnerability scanning: Run automated vulnerability scans against your IoMT network on a regular schedule. Any device with a Known Exploited Vulnerability (KEV) flagged by CISA requires immediate remediation or compensating controls.
• Firmware update management: Where manufacturers release firmware updates, apply them promptly and track update status per device. For end-of-life devices that receive no updates, document the compensating controls in your risk assessment.
• Behavioral anomaly detection: Normal medical device behavior is highly predictable. An infusion pump that suddenly starts making DNS queries or connecting to external IP addresses is almost certainly compromised. Deploy network behavioral analytics that flags deviations from baseline device behavior.
• Incident response playbooks: Every IoMT security event needs a defined response protocol: how to isolate a compromised device, how to preserve clinical care continuity during isolation, who is notified, and when OCR breach notification is triggered.

FDA Cybersecurity Requirements for Medical Devices in 2026

For medical device manufacturers specifically, the FDA's cybersecurity requirements now apply to every device submitted for 510(k), De Novo, or PMA review.

What the FDA requires in 2026:

The FDA's 2023 Cybersecurity Guidance and the Consolidated Appropriations Act (2023) made these requirements mandatory for medical devices. Any device submission in 2026 that does not include a cybersecurity plan will be refused acceptance by the FDA.

For UK-based medical device manufacturers: The MHRA has issued parallel guidance aligning closely with the FDA's cybersecurity requirements. Devices seeking UK Conformity Assessed (UKCA) marking or CE marking under EU MDR require documented cybersecurity controls and post-market surveillance commitments.

For GCC-based manufacturers: Saudi Arabia's SFDA has specific SaMD guidance that references international standards including IEC 62443 for device cybersecurity. UAE's MOHAP digital health framework is developing equivalent requirements. Check current SFDA guidance for the most recent requirements before any Saudi market submission.

Read More: UAE Digital Health 2026: NABIDH, DOH, Malaffi, and Riayati Explained

IoMT HIPAA Compliance Checklist

Use this to assess your current posture before your next hospital contract, security audit, or regulatory review.

Conclusion

As healthcare organizations connect more devices, IoMT security is no longer just an IT concern, it is a compliance, patient safety, and business continuity requirement. Every connected monitor, infusion pump, imaging system, or wearable sensor expands your attack surface and introduces new HIPAA obligations.

The organizations that succeed in 2026 will be those that treat security as a core part of their IoMT architecture, not an afterthought. By implementing strong device authentication, network segmentation, encryption, continuous monitoring, and regulatory-ready documentation, health IT teams can reduce risk while continuing to innovate.

Secure IoMT deployments not only protect patient data but also strengthen trust with hospitals, regulators, and healthcare partners.